Your browser doesn't support javascript.
loading
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Correa, Rohann J M; Valdes, Yudith Ramos; Peart, Teresa M; Fazio, Elena N; Bertrand, Monique; McGee, Jacob; Préfontaine, Michel; Sugimoto, Akira; DiMattia, Gabriel E; Shepherd, Trevor G.
Afiliação
  • Correa RJ; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Biochemistry and.
  • Valdes YR; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada.
  • Peart TM; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, N6A 5C1, Canada.
  • Fazio EN; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada.
  • Bertrand M; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, N6A 5W9, Canada and.
  • McGee J; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, N6A 5W9, Canada and.
  • Préfontaine M; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, N6A 5W9, Canada and.
  • Sugimoto A; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, N6A 5W9, Canada and.
  • DiMattia GE; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Biochemistry and Department of Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, N6A 5W9, Canada and Department of Oncology, University of Western
  • Shepherd TG; Translational Ovarian Cancer Research Program, London Regional Cancer Program, London, Ontario, N6A 4L6, Canada, Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, N6A 5C1, Canada, Department of Obstetrics and Gynaecology, University of Western Ontario, London, O
Carcinogenesis ; 35(9): 1951-61, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24562574
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Quinoxalinas / Autofagia / Benzilaminas / Sobrevivência Celular / Proteínas Proto-Oncogênicas c-akt / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Quinoxalinas / Autofagia / Benzilaminas / Sobrevivência Celular / Proteínas Proto-Oncogênicas c-akt / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2014 Tipo de documento: Article